Patient-Centered Outcomes

Research Consultancy

Welcome to Modus Outcomes

Qualitative Research – Advanced Psychometric Analysis – Biostatistics

Boston • London • Lyon

Modus Outcomes brings the patient voice to clinical research. Our work, grounded in the patient experience, allows us to design meaningful outcome measures to optimize decision-making about the development, commercialization and use of medical products.

Our Purpose

To ensure fairness in high-stakes decisions by advancing the accuracy and interpretability of measurements.

What Makes Us Different

Our nimble, flexible consultancy provides bespoke solutions tailored to your specific situation.
We use a unique concept-driven measurement™ approach, grounded in mixed methods research, to improve efficiency and reduce risk to sponsors.

Solutions

Patient-Centered Outcome Strategy

In partnership with you, we design bespoke PCO strategies to accumulate evidence to successfully meet your clinical development goals and beyond. Our recommendations are customized to reduce risk and optimize decision making.

18-1003_The Patients_Square_Hue1
18-1003_Ruler_Square_Hue 1
Instrument Development

We deliver fit-for-purpose patient-centered outcome measures to detect meaningful and interpretable treatment benefit. Our expertise spans all stages of instrument development.

Implementation and Use

We ensure that patient-centered outcomes evidence generation supports your product strategy, so you can fully leverage the results in your regulatory and market access plans.

18-1003_Boxes_Square_Hue1
18-1003_Training House_Square_Hue 1
Training

We act as catalysts to foster a patient-centered outcome culture across functional teams in your company. Our workshops are jargon-free and tailored to the audience. We are also excited to provide advanced PCO workshops on mixed methods research, measurement and statistics.

Spotlight On

feet-619399_1920

Spotlight on … Duchenne muscular dystrophy (DMD) and Spinal muscular atrophy (SMA)

Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA) are rare neurodegenerative diseases, which cause progressive, proximal-to-distal muscular weakness leading to loss of ambulation and motor function. Worldwide, they are the leading cause of neuromuscular disorders affecting children, which has led to an active research field to discover new DMD and SMA therapies. In February […]

Contact Us

    US Office

    CIC, 1 Broadway, 14th Floor
    Cambridge, MA 02142
    USA

    UK Office

    Suite 210b, Spirella Building
    Letchworth Garden City, SG6 4ET
    UK

    FR Office

    Wojo Grand Hôtel-Dieu
    4 place Amédée Bonnet
    69002 Lyon
    FRANCE